Loncar Cancer Immunotherapy ETF (NQ: CNCR )

27.12 USD UNCHANGED

Streaming Delayed Price Updated: 10:54 AM EST, Nov 26, 2021 Add to My Watchlist

Price and Volume

Volume	0
Open	27.12
Bid (Size)	24.63 (2)
Ask (Size)	29.50 (3)
Prev. Close	27.12
Today's Range	27.12 - 27.12
52wk Range	26.86 - 35.82
Shares Outstanding	N/A
Dividend Yield	1.29%

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

Legend Biotech Hits New 54-Week High

October 13, 2021

Biopharmaceutical company Legend BioTech (LEGN) hit a new 54-week high this Tuesday, up 103.4% this year. LEGN is a multinational biopharmaceutical company primarily engaged in the discovery and...

As U.K. Authorizes Pfizer Vaccine, Biotech ETFs Continue to Rally

December 03, 2020

Both stock index ETFs and biotech stocks and ETFs have been on a tear lately thanks to promising coronavirus vaccine developments from several major pharmaceutical companies. But this week, the U.K....

Performance

YTD	-14.03%	-14.03%
1 Month	-5.95%	-5.95%
3 Month	-11.43%	-11.43%
6 Month	-10.95%	-10.95%
1 Year	-16.15%	-16.15%

More News

3 Promising Oncology Stocks To Consider Adding To Your Portfolio

June 14, 2021

Best Biotech Stocks & ETFs for mRNA, Gene Editing

April 29, 2021

How Will Vaccine Arrivals Affect Biotech ETFs?

November 30, 2020

Biotech ETFs Remain Hot As Investors Await Upcoming Vaccine

November 27, 2020

Biotech ETFs Poised for Gains after Moderna Vaccine News

November 16, 2020

Will Moderna Vaccine News Boost Biotech ETFs?

November 12, 2020

ETF Wrap: Size doesn’t matter

December 03, 2020

ETF Wrap: the Groundhog Day of fiscal stimulus talks and the bet on volatility

October 22, 2020

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.